These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31090157)

  • 1. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
    Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M
    Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
    Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
    Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
    Gilardoni MB; Remedi MM; Oviedo M; Dellavedova T; Sarría JP; Racca L; Dominguez M; Pellizas CG; Donadio AC
    Pathol Res Pract; 2017 Jan; 213(1):66-71. PubMed ID: 27931798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
    Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
    Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
    Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
    Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.
    Kalantari E; Asgari M; Nikpanah S; Salarieh N; Asadi Lari MH; Madjd Z
    Pathol Oncol Res; 2017 Oct; 23(4):793-802. PubMed ID: 28083789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
    Liu BQ; Wu YD; Li PH; Wei JX; Zhang T; Liu RL
    Asian J Androl; 2007 Nov; 9(6):821-6. PubMed ID: 17968469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
    Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
    Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.
    Eiro N; Medina A; Gonzalez LO; Fraile M; Palacios A; Escaf S; Fernández-Gómez JM; Vizoso FJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expressions of TFF1 and TFF3 in prostate cancer and prostatic intraepithelial neoplasia and their clinical significance].
    Liu M; Jin RS
    Zhonghua Nan Ke Xue; 2015 Apr; 21(4):315-9. PubMed ID: 26027097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue.
    Jonmarker S; Glaessgen A; Culp WD; Pisa P; Lewensohn R; Ekman P; Valdman A; Egevad L
    APMIS; 2008 Jun; 116(6):491-8. PubMed ID: 18754323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue.
    Xu C; Zhou T; He M; Sun Y
    Urol Oncol; 2010; 28(3):314-9. PubMed ID: 19070519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
    Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
    Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of epithelial/stromal caveolin-1 expression in prostatic hyperplasia, high grade prostatic intraepithelial hyperplasia and prostatic carcinoma and its correlation with microvessel density.
    Mohammed DA; Helal DS
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):25-31. PubMed ID: 28259631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased immunoexpression of prostate inhibin peptide in prostatic carcinoma: a study with monoclonal antibody.
    Zhang PJ; Driscoll DL; Lee HK; Nolan C; Velagapudi SR
    Hum Pathol; 1999 Feb; 30(2):168-72. PubMed ID: 10029444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions.
    Levakov AF; Kaćanski MM; Vucković N; Zivojinov M; Amidzić J; Sabo JI
    Vojnosanit Pregl; 2015 Oct; 72(10):906-13. PubMed ID: 26665557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.